Testing effectiveness (Phase 2)Not Yet RecruitingNCT07485010
What this trial is testing
Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
Who this might be right for
Mycobacterium Abscessus Pulmonary DiseaseMycobacterium Abscessus InfectionNon-Tuberculous Mycobacterial (NTM) Infections+1 more
The University of Queensland 300